Susquehanna International Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,000
Closed -$944K 30
2020
Q4
$944K Sell
10,000
-20,000
-67% -$1.75M 0.69% 25
2020
Q3
$2.61M Sell
30,000
-5,000
-14% -$433K 1.38% 20
2020
Q2
$3.06M Hold
35,000
1.27% 23
2020
Q1
$2.89M Buy
+35,000
New +$3.12M 1.17% 22
2019
Q4
Sell
-58,700
Closed -$5.1M 94
2019
Q3
$5.1M Buy
58,700
+29,400
+100% +$2.64M 1.11% 25
2019
Q2
$2.67M Sell
29,300
-1,167
-4% -$98.8K 0.87% 31
2019
Q1
$2.63M Buy
30,467
+20,311
+200% +$1.63M 0.65% 38
2018
Q4
$781K Buy
+10,156
New +$791K 0.61% 26

Other funds holding NVS

Susquehanna International Securities's NVS Position: Q3 2024 in Review

Susquehanna International Securities opened a new position in Novartis (NVS) in Q3 2024: 25,400 shares worth $2.92M. The stake represents 0.69% of the portfolio and ranks #15 among its holdings. This is a return to the name: Susquehanna International Securities previously reported a position in NVS as recently as Q4 2023.

Susquehanna International Securities first reported a position in NVS in Q4 2018 and has held it in 7 quarters since. The position peaked at $11.2M in Q4 2020. 1,312 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Susquehanna International Securities held 25,400 shares of Novartis worth $2.92M as of Q3 2024.
  • Novartis was a new Susquehanna International Securities position in Q3 2024.
  • Novartis made up 0.69% of Susquehanna International Securities's portfolio in Q3 2024, its #15 holding.
  • Susquehanna International Securities first reported a position in Novartis in Q4 2018 and has held it in 7 quarters since.
  • Susquehanna International Securities's Novartis position peaked at $11.2M in Q4 2020.
  • 1,312 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Susquehanna International Securities's 13F filing for Q3 2024, filed 14 Nov 2024.